Standard Treatments and the Single-Inhaler Approach
At a Glance
Nighttime asthma symptoms can mean that asthma control needs review rather than a bedtime-only pill. When prescribed, a MART/SMART inhaler containing an anti-inflammatory steroid and formoterol can provide both maintenance and relief. Inhaler technique, daily use, reflux, and sleep apnea also matter.
When asthma disrupts your sleep, it is a clear message from your body that your current treatment plan warrants clinical review. Modern medical guidelines, such as those from the Global Initiative for Asthma (GINA), no longer view nocturnal asthma as a separate problem to be treated with “nighttime-only” pills. Instead, they emphasize stabilizing your airways 24 hours a day to prevent symptoms from ever starting [1][2].
Important: Inhaler approvals, formulations, and treatment steps vary. Never change your prescribed dosing, substitute inhalers, or combine medications without direct instructions from your prescribing clinician.
The Shift Away from “Relief Only”
For decades, many patients were taught to reach for a SABA (short-acting beta-agonist, such as albuterol) whenever they woke up wheezing. While these “rescue” inhalers quickly relax the muscles around your airways, they do nothing to treat the underlying inflammation that caused the narrowing in the first place [3].
Current guidelines now strongly recommend against using a SABA as your only treatment [4]. Frequent use of a SABA is associated with poorer outcomes and typically indicates that the underlying airway inflammation is undertreated [3][5]. Appropriately prescribed SABA remains a part of some treatment plans when used correctly alongside the recommended daily controller strategy.
The MART/SMART Strategy: A Single-Inhaler Approach
For many adults, a preferred treatment strategy today is known as MART or SMART (Maintenance and Reliever Therapy) [5]. When specifically prescribed by your doctor, you use one single inhaler that contains two medications: an ICS (inhaled corticosteroid) to lower inflammation and formoterol, a fast-acting but long-lasting bronchodilator [6].
How MART works for your 24-hour cycle:
- Daily Maintenance: For those prescribed MART at higher treatment steps, you take your prescribed puffs every morning and evening to keep your airways stable. (At lower steps, GINA Track 1 uses the inhaler only as-needed.) [6].
- Nighttime Relief: If you do wake up with symptoms, you use the same inhaler as your reliever. This ensures that every time you treat your symptoms, you are also giving your lungs a tiny “boost” of anti-inflammatory medicine right when they need it most [7][8].
Research has shown that this “Track 1” approach (specifically stepping up to MART) can reduce the risk of severe asthma attacks by 35% to 60% compared to stepping up to or continuing maintenance ICS-LABA plus a standard SABA rescue inhaler [9][2][10].
(Note: Track 2 involves a daily maintenance ICS and a separate SABA rescue inhaler. Not every combination inhaler can be used as a reliever. Follow your doctor’s exact instructions.)
Why “Chronotherapy” Isn’t the Standard
You may wonder if you should simply take your medication right before bed to counter the natural 4:00 AM dip in lung function. While scientists are studying “smart” pills that release medicine at specific times, current clinical practice focuses on 24/7 stabilization [11][12].
The goal of modern therapy is to reach a level of control where your airways are so stable that the natural biological rhythms of the night no longer cause you to wake up [1]. If you are still waking up frequently, it usually means the “baseline” inflammation in your lungs is too high, rather than the timing of your dose being wrong [5].
Steps Before “Stepping Up”
If your nighttime symptoms persist, your doctor will likely review several factors before increasing your medication dose:
- Inhaler Technique: If the medicine doesn’t reach the small airways deep in your lungs, it cannot prevent nighttime narrowing [5].
- Adherence: Are you using your controller inhaler every single day, even when you feel well [13]?
- Uncontrolled Triggers: Are issues like acid reflux (GERD) or sleep apnea (OSA) working against your asthma medication [5]?
By focusing on total airway stability rather than just “putting out fires” at 3:00 AM, most patients can work toward a future where they sleep through the night without interruption.
Common questions in this guide
What is the MART/SMART single-inhaler approach for nocturnal asthma?
Is albuterol alone enough if asthma wakes me at night?
Should I take my asthma medicine only at bedtime?
What should be checked before my asthma treatment is increased?
How many puffs of my reliever inhaler can I take in 24 hours?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Treatment approaches
Would a single-inhaler approach like MART or SMART be appropriate for my treatment plan?
Reliever inhaler use
How could my doctor tell whether my reliever use means my airway inflammation needs more treatment?
Inhaler technique
Could my inhaler technique be affecting how well my medicine reaches my airways at night?
Get notified when new evidence is published on nocturnal asthma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (13)
- 1
Asthma maintenance and reliever therapy: Should this be the standard of care?
Cusack RP, Satia I, O'Byrne PM
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2020; (125(2)):150-155 doi:10.1016/j.anai.2020.04.009.
PMID: 32339657 - 2
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
Reddel HK, Bacharier LB, Bateman ED, et al.
Respirology (Carlton, Vic.) 2022; (27(1)):14-35 doi:10.1111/resp.14174.
PMID: 34668278 - 3
Beta2-agonist and anti-inflammatory combination therapy for asthma rescue: a paradigm shift in asthma care.
Skolnik N, Stieritz J, Akers J, et al.
Frontiers in medicine 2026; (13()):1826737 doi:10.3389/fmed.2026.1826737.
PMID: 42305977 - 4
Current perspectives on β2-adrenergic receptor agonists in asthma: navigating from track to track within GINA recommendations.
Calzetta L, Rogliani P
Expert opinion on pharmacotherapy 2026; (27(11)):1085-1095 doi:10.1080/14656566.2026.2702385.
PMID: 42444391 - 5
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
Reddel HK, Bacharier LB, Bateman ED, et al.
The journal of allergy and clinical immunology. In practice 2022; (10(1S)):S1-S18 doi:10.1016/j.jaip.2021.10.001.
PMID: 34718211 - 6
A Practical Guide to Implementing SMART in Asthma Management.
Reddel HK, Bateman ED, Schatz M, et al.
The journal of allergy and clinical immunology. In practice 2022; (10(1S)):S31-S38 doi:10.1016/j.jaip.2021.10.011.
PMID: 34666208 - 7
Achieving asthma control with ICS/LABA: A review of strategies for asthma management and prevention.
Aalbers R, Vogelmeier C, Kuna P
Respiratory medicine 2016; (111()):1-7.
PMID: 26614594 - 8
AIR and MART approach to asthma treatment.
Bhugra R
Drug and therapeutics bulletin 2026; (64(7)):108-111 doi:10.1136/dtb.2023.000058.
PMID: 42120188 - 9
Inhaled Reliever Therapies for Asthma: A Systematic Review and Meta-Analysis.
Rayner DG, Ferri DM, Guyatt GH, et al.
JAMA 2025; (333(2)):143-152 doi:10.1001/jama.2024.22700.
PMID: 39465893 - 10
Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma: A Systematic Review and Meta-analysis.
Beasley R, Harrison T, Peterson S, et al.
JAMA network open 2022; (5(3)):e220615 doi:10.1001/jamanetworkopen.2022.0615.
PMID: 35230437 - 11
Circadian-guided asthma therapy: compressed-coated chronotherapeutic tablets for precision early-morning drug delivery.
Sindhu K, Kumar P, Kumar A, et al.
Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 2026; (34(2)).
PMID: 42435114 - 12
Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma.
Chauhan BF, Jeyaraman MM, Singh Mann A, et al.
The Cochrane database of systematic reviews 2017; (3()):CD010347 doi:10.1002/14651858.CD010347.pub2.
PMID: 28301050 - 13
Repeated exacerbation of asthma: An intrinsic phenotype of uncontrolled asthma.
Jain N, Satish K, Abhyankar N, et al.
Lung India : official organ of Indian Chest Society 2019; (36(2)):131-138 doi:10.4103/lungindia.lungindia_434_17.
PMID: 30829247
This page explains nighttime asthma treatment options for informational purposes only and does not constitute medical advice. Do not change inhaler doses or combine medicines without guidance from your prescribing clinician.